首页> 外文期刊>Journal of the National Cancer Institute >Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.
【24h】

Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.

机译:比较来自BRCA1或BRCA2基因突变携带者和非携带者的预防性卵巢切除术标本。英国癌症研究协调委员会(UKCCCR)家族性卵巢癌研究小组。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The natural history of ovarian cancer is not well understood and, to date, there is conflicting evidence as to whether or not there is a demonstrable precursor lesion. Some women at high risk of developing ovarian cancer because of their family history elect to have a prophylactic oophorectomy. To determine whether or not a recognizable premalignant lesion could be defined in familial ovarian carcinogenesis, we reviewed ovarian tissue specimens from women whose ovaries were removed prophylactically before gene testing became available and who were tested subsequently for BRCA1 or BRCA2 gene mutations. METHODS: We analyzed ovarian tissue specimens from 37 women. The specimens were examined for the presence of the following four features: inclusion cysts, clefts and fissures, ovarian epithelial metaplasia, and the presence of papillae on the ovarian surface epithelium. The specimens were also examined closely for the presence of dysplasia and occult neoplasia. Furthermore, the occurrence of endometriosis and benign ovarian tumors was documented in these women. The protein truncation test, nonradioactive single-stranded conformation polymorphism analysis, and heteroduplex analysis, followed by DNA sequencing, were used to identify BRCA1 or BRCA2 mutations in either blood samples or ovarian tissue specimens. RESULTS: Eleven women had inherited a mutated BRCA1 or BRCA2 gene; 26 women had not. There was no difference between these groups for any of the features studied. CONCLUSIONS: Our data suggest that many of the histologic "abnormalities" described in "normal" ovaries are, in fact, variations of the normal and are not associated with the development of cancer.
机译:背景:卵巢癌的自然病程还没有被很好地理解,迄今为止,关于是否存在可证实的前体病变,有相互矛盾的证据。一些因其家族史而处于卵巢癌高发风险的妇女选择进行预防性卵巢切除术。为了确定是否可以在家族性卵巢癌发生中定义可识别的恶性病变,我们回顾了女性卵巢组织样本,这些妇女的卵巢在进行基因检测之前已被预防性切除,随后对其进行了BRCA1或BRCA2基因突变的检测。方法:我们分析了37名妇女的卵巢组织标本。检查标本中是否存在以下四个特征:包涵囊肿,裂痕和裂痕,卵巢上皮化生以及卵巢表面上皮中存在乳头。还仔细检查了标本中是否存在异型增生和隐性肿瘤。此外,这些妇女还记录了子宫内膜异位症和卵巢良性肿瘤的发生。蛋白质截断测试,非放射性单链构象多态性分析和异源双链体分析,然后进行DNA测序,可用于鉴定血液样本或卵巢组织样本中的BRCA1或BRCA2突变。结果:11名妇女遗传了一个突变的BRCA1或BRCA2基因。 26名女性没有。对于所研究的任何特征,这些组之间没有差异。结论:我们的数据表明,“正常”卵巢中描述的许多组织学“异常”实际上是正常卵巢的变异,与癌症的发展无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号